Cipher Pharmaceuticals Q3 2023 Earnings Report C$11.56 -0.17 (-1.45%) As of 03:46 PM Eastern Earnings HistoryForecast Cipher Pharmaceuticals EPS ResultsActual EPSC$0.36Consensus EPS C$0.12Beat/MissBeat by +C$0.24One Year Ago EPSN/ACipher Pharmaceuticals Revenue ResultsActual Revenue$8.14 millionExpected Revenue$6.68 millionBeat/MissBeat by +$1.46 millionYoY Revenue GrowthN/ACipher Pharmaceuticals Announcement DetailsQuarterQ3 2023Date11/9/2023TimeN/AConference Call ResourcesCPH Earnings History Cipher Pharmaceuticals Earnings HeadlinesCipher Pharmaceuticals Inc. (TSE:CPH) most popular amongst individual investors who own 57%, insiders hold 42%February 4, 2025 | finance.yahoo.comThis Healthcare Stock Could Be the Best Investment of the DecadeJanuary 31, 2025 | msn.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.March 4, 2025 | Stansberry Research (Ad)1 Canadian Stock Ready to Start 2025 With a BangJanuary 30, 2025 | fool.ca5 Best-performing Canadian Pharma Stocks (Updated January 2025)January 11, 2025 | msn.comThose who invested in Cipher Pharmaceuticals (TSE:CPH) five years ago are up 883%December 25, 2024 | finance.yahoo.comSee More Cipher Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cipher Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cipher Pharmaceuticals and other key companies, straight to your email. Email Address About Cipher PharmaceuticalsCipher Pharmaceuticals (TSE:CPH) Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.View Cipher Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? Upcoming Earnings Marvell Technology (3/5/2025)Broadcom (3/6/2025)Costco Wholesale (3/6/2025)JD.com (3/6/2025)Canadian Natural Resources (3/6/2025)Oracle (3/10/2025)Adobe (3/12/2025)PDD (3/19/2025)Micron Technology (3/20/2025)Accenture (3/20/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
